DE69814917D1 - Transdermale therapeutische vorrichtung mit capsaicin und seinen analogen - Google Patents

Transdermale therapeutische vorrichtung mit capsaicin und seinen analogen

Info

Publication number
DE69814917D1
DE69814917D1 DE69814917T DE69814917T DE69814917D1 DE 69814917 D1 DE69814917 D1 DE 69814917D1 DE 69814917 T DE69814917 T DE 69814917T DE 69814917 T DE69814917 T DE 69814917T DE 69814917 D1 DE69814917 D1 DE 69814917D1
Authority
DE
Germany
Prior art keywords
capsaicin
analogs
therapeutic device
transdermal therapeutic
application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69814917T
Other languages
English (en)
Other versions
DE69814917T2 (de
Inventor
R Robbins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Application granted granted Critical
Publication of DE69814917D1 publication Critical patent/DE69814917D1/de
Publication of DE69814917T2 publication Critical patent/DE69814917T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69814917T 1997-12-15 1998-12-08 Transdermale therapeutische vorrichtung mit capsaicin und seinen analogen Expired - Lifetime DE69814917T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US990633 1997-12-15
US08/990,633 US6239180B1 (en) 1995-11-08 1997-12-15 Transdermal therapeutic device and method with capsaicin and capsaicin analogs
PCT/US1998/025794 WO1999030560A1 (en) 1997-12-15 1998-12-08 Transdermal therapeutic device and method with capsaicin and capsaicin analogs

Publications (2)

Publication Number Publication Date
DE69814917D1 true DE69814917D1 (de) 2003-06-26
DE69814917T2 DE69814917T2 (de) 2004-02-12

Family

ID=25536360

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69836352T Expired - Lifetime DE69836352T2 (de) 1997-12-15 1998-12-08 Transdermales therapeutisches Pflaster mit Capsaicin und seinen Analogen
DE69814917T Expired - Lifetime DE69814917T2 (de) 1997-12-15 1998-12-08 Transdermale therapeutische vorrichtung mit capsaicin und seinen analogen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69836352T Expired - Lifetime DE69836352T2 (de) 1997-12-15 1998-12-08 Transdermales therapeutisches Pflaster mit Capsaicin und seinen Analogen

Country Status (11)

Country Link
US (2) US6239180B1 (de)
EP (2) EP1039802B1 (de)
AT (2) ATE344023T1 (de)
CA (1) CA2314326C (de)
CY (1) CY1107582T1 (de)
DE (2) DE69836352T2 (de)
DK (2) DK1039802T3 (de)
ES (2) ES2196640T3 (de)
HK (1) HK1030853A1 (de)
PT (1) PT1039802E (de)
WO (1) WO1999030560A1 (de)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6239180B1 (en) * 1995-11-08 2001-05-29 The Regents Of The University Of California Transdermal therapeutic device and method with capsaicin and capsaicin analogs
US6383511B1 (en) * 1999-10-25 2002-05-07 Epicept Corporation Local prevention or amelioration of pain from surgically closed wounds
GB2355934B (en) * 1999-11-05 2003-11-05 Lohmann Gmbh & Co Kg Wound dressing
AUPQ622600A0 (en) * 2000-03-15 2000-04-06 Unisearch Limited Treatment and/or prevention of ocular pain
DE10056009A1 (de) * 2000-11-11 2002-05-16 Beiersdorf Ag Hautfreundliches Wirkstoffpflaster zur transdermalen Verabreichung hyperämisierender Wirkstoffe
US7063860B2 (en) * 2001-08-13 2006-06-20 University Of Pittsburgh Application of lipid vehicles and use for drug delivery
US8110217B2 (en) * 2001-08-13 2012-02-07 University Of Pittsburgh Sphingomyelin liposomes for the treatment of hyperactive bladder disorders
EP1450824A4 (de) * 2001-11-02 2005-09-28 Elan Corp Plc Pharmazeutische zusammensetzung
AU2003270325A1 (en) * 2002-09-05 2004-03-29 Neurogesx, Inc. Compositions and kits for the removal of irritating compounds from bodily surfaces
US8623412B2 (en) * 2002-09-23 2014-01-07 Elan Pharma International Limited Abuse-resistant pharmaceutical compositions
US7687080B2 (en) * 2002-11-25 2010-03-30 Taraxos Inc. Treatment of neuropathy
US20050020690A1 (en) 2002-12-18 2005-01-27 Algorx Infiltration of capsaicin into surgical sites and open wounds
DE60322436D1 (de) * 2002-12-18 2008-09-04 Algorx Verabreichung von capsaicinoiden
US7235270B2 (en) 2003-03-10 2007-06-26 Mayeux Jerry V Pain balm
CA2521925A1 (en) * 2003-04-08 2004-10-28 Algorx Pharmaceuticals, Inc. Preparation and purification of synthetic capsaicin
EP1610742B1 (de) 2003-04-10 2015-01-21 Neurogesx, Inc. Verwendung und zusammensetzungen zur verabreichung von capsaicin
WO2004089361A1 (en) * 2003-04-14 2004-10-21 Lts Lohmann Therapie-Systeme Ag Therapeutic patch with polysiloxane matrix comprising capsaicin
DE102004009904A1 (de) * 2004-02-26 2005-09-22 Grünenthal GmbH Kit aus einem gegebenenfalls wirkstoffhaltigen Pflaster und einem Hautirritationen verhindernden Mittel
US20060100272A1 (en) * 2004-06-02 2006-05-11 Sri International Formulations for the treatment of pain
US7704522B2 (en) * 2004-09-08 2010-04-27 Clyde Morgan Topical medicament
CA2596194A1 (en) * 2004-11-24 2006-06-01 Algorx Pharmaceuticals, Inc. Capsaicinoid gel formulation and uses thereof
JP2006206471A (ja) * 2005-01-26 2006-08-10 Nitto Denko Corp テープ製剤
AU2006214289A1 (en) * 2005-02-14 2006-08-24 Neurogesx, Inc. Device for delivery of TRPV1 agonists
US20060210613A1 (en) * 2005-03-15 2006-09-21 Carliss Richard D Therapeutic wound care product
US20060222690A1 (en) * 2005-03-30 2006-10-05 Bley Keith R Low-concentration capsaicin patch and methods for treating neuropathic pain
US7771760B2 (en) * 2005-04-01 2010-08-10 Neurogesx, Inc. Oils of capsaicinoids and methods of making and using the same
US7282224B1 (en) 2006-06-09 2007-10-16 Guthy-Renker Corporation Pain relief composition
US7943666B2 (en) * 2006-07-24 2011-05-17 Trinity Laboratories, Inc. Esters of capsaicin for treating pain
US7645767B2 (en) * 2006-08-31 2010-01-12 Trinity Laboratories, Inc. Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
US20080107747A1 (en) * 2006-10-23 2008-05-08 Roederer Joy E Pain relief composition
KR101572634B1 (ko) 2008-04-04 2015-12-01 포사이트 비젼4, 인크. 통증 관리 및 시력을 위한 치료 장치
US8987328B2 (en) * 2008-10-30 2015-03-24 Trinity Laboratories, Inc. Esters of capsaicinoids as dietary supplements
US20130066283A1 (en) 2009-10-23 2013-03-14 Nexisvision, Inc. Corneal Denervation for Treatment of Ocular Pain
US8591025B1 (en) 2012-09-11 2013-11-26 Nexisvision, Inc. Eye covering and refractive correction methods for LASIK and other applications
EP2490620A4 (de) 2009-10-23 2017-03-22 Forsight Labs, Llc Biegsamer therapeutischer schild für sicht und schmerzen
EP2632405A4 (de) 2010-10-25 2016-02-24 Nexisvision Inc Verfahren und vorrichtung zur identifizierung von augenabdeckungen für bestimmte sichten
AU2012249773A1 (en) 2011-04-28 2013-11-07 Nexisvision, Inc. Eye covering and refractive correction methods and apparatus having improved tear flow, comfort, and/or applicability
CN104010635A (zh) 2011-09-09 2014-08-27 Api起源有限责任公司 包含trpv1选择性激动剂的止痛组合物及其制备和应用
US9465233B2 (en) 2012-04-20 2016-10-11 Nexisvision, Inc. Bimodular contact lenses
WO2013184239A1 (en) 2012-04-20 2013-12-12 Nexisvision, Inc. Contact lenses for refractive correction
CN104603097A (zh) 2012-05-23 2015-05-06 塞利克斯比奥私人有限公司 用于治疗多发性硬化症的组合物和方法
CN104603100A (zh) 2012-05-23 2015-05-06 塞利克斯比奥私人有限公司 用于治疗炎症性肠病的组合物和方法
EP3014345A2 (de) 2013-06-26 2016-05-04 Nexisvision, Inc. Kontaktlinsen zur refraktiven korrektur
US9341864B2 (en) 2013-11-15 2016-05-17 Nexisvision, Inc. Contact lenses having a reinforcing scaffold
WO2015116559A1 (en) 2014-01-29 2015-08-06 Nexisvision, Inc. Multifocal bimodulus contact lenses
WO2015160941A1 (en) 2014-04-15 2015-10-22 Vizuri Health Sciences Llc Topical compositions for pain relief, manufacture and use
EP3240779B1 (de) 2014-09-26 2020-10-28 Cellixbio Private Limited Zusammensetzungen und verfahren zur behandlung von epilepsie- und lipidstörungen
ES2799309T3 (es) 2014-09-29 2020-12-16 Cellix Bio Private Ltd Compuestos y composiciones para el tratamiento de esclerosis múltiple
WO2016067297A1 (en) 2014-10-27 2016-05-06 Cellix Bio Private Limited Salts of valproic acid with piperazine, ethylenediamine, lysine and/or eicosapentaenoic ecid (epa) amine derivatives for the treatment of epilepsy
EP3212626B1 (de) 2014-10-27 2018-11-07 Cellix Bio Private Limited Drei-komponenten-salze des fumarsäuremonomethylesters mit piperazin und ethylendiamin zur behandlung von multipler sclerosis
CN107207411A (zh) 2014-12-01 2017-09-26 塞尔利克斯生物私人有限公司 用于治疗多发性硬化的组合物和方法
EP3256459B1 (de) 2015-02-09 2022-07-13 Cellixbio Private Limited Zusammensetzungen und verfahren zur behandlung von mukositis
CA2994331C (en) 2015-07-31 2023-10-03 Delivra Inc. Transdermal formulations for delivery of capsaicinoids
NZ750126A (en) 2016-08-11 2022-07-01 Cellix Bio Private Ltd Compositions and methods for the treatment of irritable bowel syndrome
RU2749189C2 (ru) 2016-10-04 2021-06-07 Целликс Био Прайвет Лимитед Композиции и способы лечения ксеростомии
WO2018115984A1 (en) 2016-12-19 2018-06-28 Cellix Bio Private Limited Compositions and methods for the treatment of inflammation
KR20200034769A (ko) 2017-07-27 2020-03-31 알러간, 인코포레이티드 체지방 감소를 위한 프로스타시클린 수용체 작용제
NZ763699A (en) 2017-11-17 2022-05-27 Cellix Bio Private Ltd Compounds, compositions and methods for treatment of eye disorders and skin diseases
EP3651747A4 (de) 2017-11-17 2020-07-22 Cellix Bio Private Limited Zusammensetzungen und verfahren zur behandlung augenkrankheiten
CA3175582A1 (en) 2020-03-17 2021-09-23 Grunenthal Gmbh Repeated topical application of capsaicin patch for treating initial non-responders
US20230310351A1 (en) 2020-04-03 2023-10-05 Gruenenthal Gmbh Regimen for repeated topical application of capsaicin patch
RU2755206C1 (ru) 2020-05-20 2021-09-14 Федеральное государственное бюджетное учреждение науки Тихоокеанский институт биоорганической химии им. Г.Б. Елякова Дальневосточного отделения Российской академии наук (ТИБОХ ДВО РАН) Средство пролонгированного анальгетического действия и лекарственный препарат на его основе
US11234947B2 (en) * 2020-06-30 2022-02-01 Imperial College Innovations Limited Treatment of peripheral neuropathy induced by cancer chemotherapy

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486450B1 (en) 1980-07-14 1998-07-28 Joel E Bernstein Method of treating psoriatic skin and composition
US4313958A (en) 1980-10-24 1982-02-02 The Procter & Gamble Company Method of producing analgesia
US4424205A (en) 1982-03-18 1984-01-03 The Procter & Gamble Company Hydroxyphenylacetamides having analgesic and anti-irritant activity
US4536404A (en) 1983-06-16 1985-08-20 Dermatological Enterprises, Ltd. Method and composition for treating post-herpetic neuralgia
US4544669A (en) 1983-07-14 1985-10-01 The Procter & Gamble Company Compounds and compositions useful for producing analgesia
US4544668A (en) 1983-07-14 1985-10-01 The Procter & Gamble Company Compounds and compositions useful for producing analgesia
US4532139A (en) 1983-07-14 1985-07-30 The Procter & Gamble Company Compounds and compositions useful for producing analgesia
US4592912A (en) 1983-10-31 1986-06-03 Harriet Nickolaus Ache and pain relieving and preventing composition
US4681897A (en) 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
US4898887A (en) * 1984-12-20 1990-02-06 The Procter & Gamble Company Compounds and compositions having anti-inflammatory and analgesic activity
US4971800A (en) 1988-07-08 1990-11-20 The Regents Of The University Of California Method and compositions for enhancing the cutaneous penetration of pharmacologically active agents
US4939149A (en) 1988-10-24 1990-07-03 The United States Of America As Represented By The Department Of Health And Human Services Resiniferatoxin and analogues thereof to cause sensory afferent C-fiber and thermoregulatory desensitization
US4997853A (en) 1988-12-02 1991-03-05 Galenpharma, Inc. Method and compositions utilizing capsaicin as an external analgesic
CA1338779C (en) 1989-03-17 1996-12-10 Harry Hind Method for treating pain associated with herpes-zoster and post-herpetic neuralgia by topical application of local anesthetics
US5411738A (en) 1989-03-17 1995-05-02 Hind Health Care, Inc. Method for treating nerve injury pain associated with shingles (herpes-zoster and post-herpetic neuralgia) by topical application of lidocaine
AU5744490A (en) 1989-05-15 1990-12-18 Afferon Corporation Composition and method for neural desensitization
US5063060A (en) 1989-12-19 1991-11-05 Cisco Limited Partnership Compositions and method for treating painful, inflammatory or allergic disorders
JP2748199B2 (ja) * 1991-08-27 1998-05-06 泰一郎 岩倉 気管支喘息発作の予防と治療貼付剤
US5260313A (en) 1992-03-12 1993-11-09 National Pain Institute, Inc. Diagnosis and treatment of various neuralgias
US5431914A (en) 1992-04-17 1995-07-11 Adekunle; Michael Method of treating an internal condition by external application of capsaicin without the need for systemic absorption
JP3414423B2 (ja) * 1992-11-27 2003-06-09 積水化学工業株式会社 眠気防止用外用剤及び貼付剤
US5665360A (en) 1993-05-14 1997-09-09 Mann; Richard H. Method of treating peripheral neuropathies of the feet and legs
US5910512A (en) 1994-04-18 1999-06-08 Healthline Laboratories, Inc. Topical analgesic using water soluble capsaicin
DE4414502A1 (de) * 1994-04-26 1995-11-02 Edda Scholten Salbe zur äußerlichen Anwendung bei Schmerzen
US5665378A (en) 1994-09-30 1997-09-09 Davis; Roosevelt Transdermal therapeutic formulation
US5762963A (en) 1995-06-07 1998-06-09 Emory University Method and compositions for controlling oral and pharyngeal pain using capsaicinoids
US5788982A (en) 1995-06-16 1998-08-04 Nadoolman; Wolffe Method and composition for treating oral pain using capsaicin
US6239180B1 (en) * 1995-11-08 2001-05-29 The Regents Of The University Of California Transdermal therapeutic device and method with capsaicin and capsaicin analogs
US5854291A (en) 1996-04-23 1998-12-29 Medical Merchandising, Inc. Pain reliever and method of use
US5869533A (en) 1996-04-23 1999-02-09 Holt; Stephen D. Non-irritating capsaicin formulations and applicators therefor
US5856361A (en) 1996-04-23 1999-01-05 Medical Merchandising, Inc. Pain reliever and method of use
JP2001515492A (ja) 1997-03-13 2001-09-18 エヌ． キャンベル，ジェイムズ カプサイシンまたはカプサイシンアナログを含有する組成物および局所麻酔
JP2002503451A (ja) 1998-01-22 2002-02-05 ザ・レジェンツ・オブ・ザ・ユニバーシティー・オブ・カリフォルニア カプサイシン受容体をコードする核酸配列
WO1999043322A1 (en) 1998-02-24 1999-09-02 Wake Forest University Method for the treatment of pain, including chronic and female specific pain

Also Published As

Publication number Publication date
ES2272827T3 (es) 2007-05-01
EP1039802A4 (de) 2002-01-23
EP1316308B1 (de) 2006-11-02
HK1030853A1 (en) 2001-05-25
DK1316308T3 (da) 2007-03-05
DE69814917T2 (de) 2004-02-12
CY1107582T1 (el) 2013-03-13
EP1039802B1 (de) 2003-05-21
ATE344023T1 (de) 2006-11-15
US6239180B1 (en) 2001-05-29
DK1039802T3 (da) 2003-09-22
ES2196640T3 (es) 2003-12-16
EP1316308A1 (de) 2003-06-04
CA2314326A1 (en) 1999-06-24
DE69836352T2 (de) 2007-05-24
WO1999030560A1 (en) 1999-06-24
US20010002406A1 (en) 2001-05-31
EP1039802A1 (de) 2000-10-04
DE69836352D1 (de) 2006-12-14
ATE240723T1 (de) 2003-06-15
CA2314326C (en) 2008-11-18
PT1039802E (pt) 2003-10-31

Similar Documents

Publication Publication Date Title
DE69814917D1 (de) Transdermale therapeutische vorrichtung mit capsaicin und seinen analogen
EP1201241B8 (de) Zusammensetzungen enthaltend Capsaicin oder Capsaicin Analoge und ein Anästhetikum
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
BR9815439A (pt) Analgesia contìnua obtida com buprenorphine
ATE161735T1 (de) Pharmazeutisches mittel zur behandlung von mit herpes-zoster assoziierten schmerzen und von postherpetischen neuralgien mittels lokaler anwendung von lokalanästhetika
GEP20002146B (en) Therapeutic Peptide Derivatives
DE69213814D1 (de) Melatoninderivate zur Behandlung von Schlafstörungen und zur Pre-Anästhesie
ES2173111T3 (es) Uso de fenserina para la preparacion de medicamentos para el tratamiento de desordenes cognoscitivos.
NO305581B1 (no) Anvendelse av et benaktivt fosfonat i kombinasjon med et °strogenhormon, og preparat i enhetsdoseform for behandling av osteoporose
DE69739050D1 (de) Verwendung von Thrombopoietin als Medikament zur Therapie und Vorbeugung der Thrombocytopenie
DE69330150D1 (de) Pharmazeutische Zusammensetzungen zur transdermalen Verabreichung von Melatonin und/oder seine Analoge
DE69111974D1 (de) Verwendung von Lithium zur Behandlung oder Prophylaxe von Molluscum contagiusum.
CY1108368T1 (el) Διαδερμικη συσκευη φελοδιπινης και μεθοδοι
RU94002713A (ru) Способ лечения детей с синдромом удлиненного интервала qт (романо-уорда)
RU94001389A (ru) Способ лечения псориаза

Legal Events

Date Code Title Description
8364 No opposition during term of opposition